GLP-1 Agonists: Unpacking Their Complex Link to Mood and Suicide Risk
Implications of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) for Mood Disorders and Suicide Risk.
Study Design
Population
Not specified in the digest, but the headline suggests a focus on patients using GLP-1 agonists.
Intervention
GLP-1 agonists, specifically semaglutide, are the class of compounds being investigated.
Outcome
The primary outcome investigated is the complex link between GLP-1 agonists and mood and suicide risk.
Abstract
Implications of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) for Mood Disorders and Suicide Risk.
Authors: McIntyre RS
Journal: Biological psychiatry (2026)
DOI: 10.1016/j.biopsych.2026.04.019